
Cytek Biosciences, Inc.
Cytek Biosciences, Inc. (CTKB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTKB · as of Jun 8, 2026
Key Statistics
Explore Cytek Biosciences, Inc. Data
ctkb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 60.0%
The CTKB analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $5.13, representing +26.76% upside from the current price of $4.05.
Competitors & Peers
ctkb competitorsStock Performance
Full HistoryAbout Cytek Biosciences, Inc.
Cytek Biosciences, Inc. a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and nor…
what is cytek biosciences, inc. · ctkb stock overview · cytek biosciences, inc. company profile · who is cytek biosciences, inc. ceo · ctkb NASDAQ · cytek biosciences, inc. headquarters · cytek biosciences, inc. business segments
About Stock Overview & Key Data
Cytek Biosciences, Inc. (CTKB) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 23, 2021. As of the latest trading session, CTKB stock price is $4.05, with a market capitalization of $522.6M. The stock has returned +14.89% over the past 12 months and -19.01% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Cytek Biosciences, Inc. stock is Buy, with an average 12-month price target of $5.13. In fiscal year 2025, Cytek Biosciences, Inc. reported revenue of $201.5M and net income of -$66.5M. For detailed data — including Cytek Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cytek Biosciences, Inc. (CTKB) stock price is $4.05. The stock is traded on NASDAQ under the ticker symbol CTKB. The 52-week range is $2.90 – $6.18.